For patients with Parkinson's disease, dopamine receptor agonists and monoamine oxidase B inhibitors can be taken as prescribed by doctors to help improve symptoms. They can also use anticholinergic drugs, amantadine, and levodopa preparations under the guidance of doctors for treatment.
1. Dopamine receptor agonists: such as Pramipexole Dihydrochloride Tablets and Piribedil Sustained-Release Tablets, which can increase the dopamine content in the substantia nigra striatum and thereby alleviate symptoms like bradykinesia;
2. Monoamine oxidase B inhibitors: such as Selegiline Tablets and Rasagiline Tablets, which can promote the release of dopamine in the brain, prevent its catabolism, and increase neuronal sensitivity to dopamine, thus achieving a certain effect;
3. Anticholinergic drugs: such as Benzhexol Tablets and Scopolamine Patch, which can produce effects by blocking the binding of acetylcholine to muscarinic M-receptors and alleviate tremor symptoms to a certain extent;
4. Amantadine: including Memantine Tablets and Bromocriptine Mesylate Tablets, which increase the concentration of dopamine in the brain by antagonizing the effects of α-adrenergic receptors, thus achieving the purpose of controlling the disease;
5. Levodopa preparations: one of the most widely used compound preparations in clinical practice, mainly composed of levodopa and carbidopa, suitable for the treatment of patients with moderate to severe or elderly Parkinson's disease.
In addition to the common types mentioned above, various types of drugs such as dopamine receptor agonists, catechol-O-methyltransferase inhibitors, and monoamine oxidase A inhibitors can also be used for treatment.
It is recommended that patients strictly follow the guidance of professional physicians in medication and avoid self-medication blindly to prevent adverse reactions. If there are any obvious discomfort or other abnormalities during the treatment, they should seek medical attention promptly to avoid delaying the condition.
